This post was just published on ZYX Buy Change Alert. BLCM is long with an average price of $19. As of this writing it is trading at $25.84. Consider taking profits on a 20% tranche in the zone of $25 to $26.73. Also consider stops on a 20% tranche in the
This post was published on ZYX Buy Change Alert. JUNO is developing immunotherapies for lymphomas, leukemias and other cancers. It is an upcoming IPO This is a call to buy in the IPO at the IPO price. To be clear, this is not a call to buy the stock post IPO
This post was published on ZYX Buy Change Alert. BLCM is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors, as well as orphan inherited blood disorders. It is an upcoming IPO This is a
This post was just published on ZYX Buy Change Alert. RAD is long from an average of $4.96 and 70% of the full core position size is being held. In the premarket as of this writing RAD is trading at $6.72. Consider taking profits on a 10% tranche in the zone
This post was just published on ZYX Short Change Alert. Take profits and exit VA in the zone of $29. to $31.43. The stock is trading at $31.31 as of this writing. You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A
On Dec. 1, 2014, The Arora Report published column regarding a signal that oil had lower to go. At that time, Brent crude, the international benchmark for the price of oil, was trading at $69.74, but has since dropped to $61.57. West Texas Intermediate (WTI) the benchmark in the U.S.,
(The Weekly Digest reproduces the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers. ) SMART MONEY SLAMS JOHNNY-COME-LATELYS December 12, 2014 Yesterday morning less informed investors got excited about the Retail Sales number that we shared with you
This post was just published on ZYX Short Change Alert. Shortly after 11:30 AM PTCT began running up on a buyout rumor. With its clinical trials halted, the stock should have fallen into the $30’s, the timing of the rumor is suspect. It is not uncommon for unsavory characters to spread false
This post was just published on ZYX Short Change Alert. Consider changing the stop zone to a mental zone of $53.33 – 53.87. Also consider adding a 10% tranche in the zone of $ 51.73 -52.73. You are receiving less than 2% of the content from our paid services …TO RECEIVE
(The Weekly Digest reproduces the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers. ) BLOWOUT EMPLOYMENT NUMBER December 5, 2014 November Non Farm Payrolls came at 321K vs. 231K consensus. Temporarily stocks like it and bonds are not responding